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Introduction 
Metastatic cancer is the cause of 
ninety percent of cancer-related 
deaths.1 While great strides have 
been made in cancer research, there 
is still much to learn about the 
mechanisms tumor cells undergo in 
the metastatic cascade. As illustrated 
in Figure 1, the metastatic cascade 
begins with tumor cells detaching 
from the primary tumor, at which 
point there are two main options:  
tumor cells either enter the 
lymphatic system or enter the 
vasculature. The focus of this study is 
the metastatic cascade with respect 
to the vasculature. Once in the 
bloodstream, hematogenous 
dissemination occurs. The tumor cells travel through the bloodstream until they either adhere at a 
distant site or die. If they adhere, they are then able to extravasate and form a secondary tumor.2 In 
order to better understand metastatic cancer we must be able to model it accurately. Creating a more 
physiologically relevant model will better shed light on the cellular interactions taking place in vivo. We 
were able to create a microfluidic device to more stably model flow patterns in the body. Previously, we 
used a parallel plate flow chamber, which was inconsistent in its functionality. The microfluidic device 
enables eight trials to be run simultaneously as opposed to one at a time. As well, variation from trial to 
trial has been decreased by creating a chamber that has constant dimensions, rather than one that 
varies from trial to trial based on the vacuum pulled.  
 
Methodology  
Mask Fabrication  
The design used for the mask was developed by Chau et. al. and 
altered slightly to better fit our needs.3 With the design, the fluidic 
device can achieve multiple shear stresses at once by joining two 
reservoirs with channels of various lengths, as in Figure 2. The 
pressure drop across the channels is constant because of common 
pressure in the entrance and exit reservoirs; thus the flow rate in 
each channel dictates the respective shear stresses. The flow rate in 
each channel varies based on the length of the channel. Using ratios 
of the channel lengths, the shear stresses could be predicted for any 
given flow rate. The final design consisted of eight channels of four 
different lengths. 
Figure 2: Microfluidic device design 
Figure 1: Metastatic Cascade 
A few adjustments were made to the original design, one of which being the ratio of channel lengths. 
The original design had shears ranging from 0.7-130 dynes/cm2. For our purposes the shear stresses only 
needed to range from 1-15 dynes/cm2 so the relative lengths of the channels had to be recalculated. As 
well, we need replicates of the trials, so our design had four lengths with two channels at each length. 
Calculations to determine the shear stress at the wall of the channels were done using the following 
equations. The flow rate of each channel was calculated using the following equation:  
𝑄𝑡𝑜𝑡𝑎𝑙 =  �𝑄𝑖 
 Where Qtotal is the overall volumetric flow rate 
  Qi is the volumetric flow rate in each individual channel 
Then with the flow rate in each channel, the shear stress at the wall can be calculated with the following 
equation:  
𝜏𝑤 =
6𝜇𝑄
𝑤ℎ2
 
Where τw is the shear stress at the wall 
μ is the viscosity of the fluid  
Q is the volumetric flow rate 
w is the channel width 
h is the height of the channel 
Knowing the desired shear stresses – 1, 2, 5, and 10 dynes/cm2 – and the flow rates we were capable of 
achieving with the peristaltic pump, channel lengths were designed to be 3, 6, 15, and 30mm long. Once 
the design was generated in AutoCAD, a photomask was made by FineLine Imaging.  
Chamber Development  
First a mask must be made on which 
polydimethylsiloxane (PDMS) chambers can be 
cast.  The process begins by spincoating a layer of 
SU-8, a negative photoresist, onto a glass slide. 
After the SU-8 is spun to an even height across the 
slide, the slide with SU-8 undergoes a 70 minute 
soft-bake at 95°C. Next, the mask aligner is used to 
cross-link the SU-8 into a permanent pattern using 
ultraviolet (UV) light; areas exposed to UV light is 
dictated by the photomask. Finally, there is a post 
exposure bake, followed by washing steps that 
removes all the undesired SU-8 that was not cross-
linked because it was not exposed to UV light in the 
mask aligner. The masks were produced in the 
CeNSE microfabrication lab and all of the protocols 
were developed with the help and guidance of Dr. 
Chuck May.  
The second step in this process is to cast the microfluidic chamber using the mask. Twenty grams of 
degassed PDMS, mixed with 10% by mass curing agent, is poured onto the mask and then allowed it to 
solidify for 70 minutes in an oven at 65°C. Once set, the PDMS is removed from the oven, peeled off the 
Figure 3: Overview of microfluidic fabrication 
mask and inlet and outlet port holes were punched through the PDMS. To create a chamber, the PDMS 
was permanently attached to a glass slide with plasma oxygen. The slide and PDMS were exposed to 
plasma oxygen at 600microns for 90 seconds and then immediately pressed together, creating a 
permanent bond between the glass slide and PDMS chamber. Once the chamber is bound to the glass 
slide, inlet and outlet ports are inserted into the punched holes and PDMS is cast around the ports to 
permanently bond them in place.  
Seeding Cells  
The final step in device fabrication is cell growth on the channel floors under flow conditions. This will 
create an environment which mimics the vasculature of the body. In such a setting, cancer cell adhesion 
and detachment to endothelial cells can be tested.  After complete assembly of the microfluidic device, 
it must be sterilized by pumping a 10% bleach solution through the chamber, followed by a 70% ethanol 
solution, and then cell media should be pumped into the chamber and allowed to set overnight to draw 
any remaining toxins out of the PDMS. Finally, fresh cell media should be pumped through the chamber 
and then aspirated out.  
To seed cells in the chamber, Attachment Factor (Cell Systems) is be pumped through the chamber with 
a syringe and then aspirated out. The chamber is allowed to dry before a suspension of cells at a 
concentration of 1x106cells/mL is then syringed into the chamber. Cells are permitted a 6 hour static 
period to firmly adhere to the bottom of the chamber. Once the cells adhere to the chamber, they need 
a continuous supply of nutrients. The nutrients are supplied in the form of media. To constantly feed 
media through the chamber, tubing is run from a media reservoir, through a peristaltic pump and to the 
chamber inlet port where it finally reaches the cells. From there, tubing leads the media back out into a 
waste container.  
Results & Discussion  
A fabrication process was developed and a 
microfluidic device was successfully fabricated, as 
seen in Figure 4. The device contains two inlet 
ports, one is a perfusion inlet to provide nutrient-
rich media to the endothelial cells growing on the 
slide, and the second is for introduction of a second 
cell population, such as cancer cells to test their 
adhesion to an endothelial monolayer. A phenol 
dye was used to monitor flow patterns as it was 
pumped into the chamber to ensure that the fluid 
was dispersed evenly to each channel. The inlet 
reservoir was long enough that the fluid spread 
across the width of the chamber before filling the 
length of the reservoir, so fluid reached each 
channel at approximately the same time. As well, the oxygen plasma adhesion of the PDMS to the glass 
slide was effective. With the phenol dye it is evident that there are not any leaks around the perimeter 
of the chamber. Phenol dye was left in the chamber overnight to ensure that leakage would not occur 
after longer periods of time with the same positive results. The microfluidic was successfully produced 
and capable of flowing fluid through the chamber.  
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Figure 4: Microfluidic with a dye to display channels 
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The channel widths were measured to validate 
the fabrication process. The goal channel width 
was 200μm, using AxioVision software on a Nikon 
microscope the PDMS channel widths were 
measured to be 200-215μm wide, as seen in 
Figure 5. The slightly wider portions of the 
channel are likely due cross-linking of SU-8 
around the pattern edges under the mask where 
ultraviolet light should not have reached. This 
would lead to slightly less SU-8 being removed 
during the washing step of the mask fabrication; 
thereby causing the mask to cast channels slightly 
wider than desired. The range of channel widths 
encompassed the original goal and the maximum 
deviation was less than 10% different from the 
goal. The PDMS edges of the channels appear to 
be well defined.  
In order to determine the shear stresses each of the channels were experiencing, the overall flow rate 
had to be determined. The flow rate of media through the chamber is dictated by the peristaltic pump. 
Prior to experimentation, the peristaltic pump had to be calibrated with cell media at 37°C. A calibration 
curve was generated by measuring the volume of fluid pumped over a period of time at ten different 
pump settings. The calibration 
curve (Figure 6) allows 
calculation of the pump setting 
to achieve a desired volumetric 
flow rate using the equation: 
S = 0.312Q + 0.287 
where S is the pump setting and 
Q is the total volumetric flow 
rate. Utilizing the calibration 
curve equation, the pump 
setting to achieve a total flow 
rate of 0.033mL/min thereby 
producing shear stresses of 1, 2, 
5 and 10 dynes/cm2 in the 
respective channels, should be 
0.297, indicated by the red 
circle on the calibration curve. 
This setting is specific to the 
microfluidic devices and the fluid being pumped (cell media at 37°C). The calibration curve yielded an r-
squared value of 0.9996, indicating a strong linear relationship in the data. 
As well, cells were successfully seeded in the microfluidic device during the 6hr static period, indicating 
that the device environment is not toxic to the cells. However, multiple problems have occurred which 
have prevented successful cell growth under flow conditions. Endothelial cells were beginning to adhere 
to the glass floor of the chamber at the end of 6 hours as indicated by their spreading, but the cells were 
S = 0.3124Q + 0.2865 
R² = 0.9996 
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Figure 5: Measurement of channel widths between the 
PDMS walls. 
Figure 6: Calibration curve for the setting of the pump versus the resulting 
volumetric flow rate. 
very sparse and the cell count was low. Upon induction of flow the endothelial cells become detached 
from the floor of the microfluidic. To date, cells have not successfully been grown in the microfluidic 
device under flow conditions.  
Conclusions 
A microfluidic device fabrication protocol was successfully developed; the protocol yielded channels of 
the appropriate width and lengths, which can contain liquids without leakage for extended periods of 
time, and does not appear to be toxic to cells. From there, calculations and calibrations were preformed 
to achieve the desired shear stresses at the channel floors within microfluidic device. Looking forward, 
further steps must be taken to finalize the process by which endothelial cells can be cultured under flow 
conditions. Potential solutions may include using a higher density of cells in solution when seeding cells 
in the device. As well, different agents could be used to seed cells more firmly to the slide. We have 
been using Attachment Factor, which consist of a serum in a collagen medium; instead we could try 
fibronectin. Another potential fix may be that rather than turning the pump directly on, it should be 
ramped up to the appropriate setting. The immediate dynamic change may be too rough of a condition 
for the cells to survive. Along the same line, the cells may need a better developed matrix before flow is 
induced, so a longer static incubatory time could be another potential solution. Once cells can be 
cultured, the device will have a breadth of applications.  
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